STOCK TITAN
  1. Home
  2. CEMI

Chembio Diagnostics (CEMI) Stock Price, News & Analysis

CEMI NASDAQ

Company Description

Chembio Diagnostics (NASDAQ: CEMI) is classified in the pharmaceutical preparation manufacturing industry within the Manufacturing sector.

This page collects what Stock Titan holds for CEMI, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.

Stock Performance

Chart
$—
0.00%
0.00
Last updated:
-
Performance 1 year
$0.0
Market Cap
36.7M
Shares outstanding

Latest News

View All
—

Life Science Outsourcing, Inc. Welcomes Neil A. Goldman as Chief Financial Officer

—

Biosynex Completes Acquisition of Chembio Diagnostics, Inc.

acquisition
-0.22%

Chembio Stockholders Urged to Tender Shares Before 6:00 P.M., New York City Time, on April 26, 2023

+4.42%

Biosynex Extends Tender Offer for the shares of Chembio Diagnostics, Inc.

+0.16%

Chembio Stockholders Reminded to Tender Shares Before 6:00 P.M., New York City Time, on April 12, 2023

+0.25%

Chembio’s CEO Letter to Stockholders

Chembio Diagnostics has 10 recent news articles. Of the recent coverage, 5 articles coincided with positive price movement and 3 with negative movement. Key topics include acquisition. View all CEMI news →

SEC Filings

View All

No SEC filings available for CEMI.

Financial Highlights

—
Revenue (TTM)
—
Net Income (TTM)
—
Diluted EPS (TTM)
—
Operating Cash Flow
—
Net Profit Margin
—
Oper. Profit Margin

Upcoming Events

Short Interest History

Last 12 Months

Days to Cover History

Last 12 Months

CEMI Company Profile & Sector Positioning

Chembio Diagnostics (CEMI) operates in the Pharmaceutical Preparation Manufacturing industry within the broader Manufacturing sector and is listed on the NASDAQ.